AGX.NYSEArgan INC

Form 4: Director Jeffrey Jr. Exercises Options, Sells ARGAN Stock

Sentiment:

Insider Transaction Report


ARGAN Director John R. Jeffrey Jr. exercised stock options and subsequently sold a portion of his common stock holdings.

Summary

  • Director John R. Jeffrey Jr. exercised 10,000 stock options on January 16, 2026, at an exercise price of $45.75 per share, utilizing a net settle method.
  • This transaction resulted in the acquisition of 8,636 shares of ARGAN INC common stock.
  • On January 20, 2026, Jeffrey Jr. sold 2,700 shares of ARGAN INC common stock on the open market at an average price of $380.60 per share.
  • Following these reported transactions, direct beneficial ownership of common stock is 13,192 shares, and indirect beneficial ownership is 8,000 shares held in an IRA.
  • Direct beneficial ownership of options to purchase common stock is 11,500.

Sentiment

Score: 6

Explanation: The exercise of options indicates confidence at the time of award and a significant personal gain, which is positive. However, the subsequent sale of shares, while potentially for diversification or personal liquidity, slightly offsets the positive sentiment from the exercise. The director's overall direct common stock holdings increased.

Positives

  • The director exercised stock options, indicating a prior belief in the company's value at the time the options were awarded.
  • The exercise price of $45.75 per share is significantly lower than the sale price of $380.60 per share, demonstrating substantial personal gain for the director from the options.

Negatives

  • The director sold 2,700 shares of common stock, which could be perceived as a reduction in direct exposure to the company's equity, although the overall direct common stock ownership increased from 7,256 shares to 13,192 shares due to the option exercise.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

This is an insider transaction filing (Form 4) and does not provide broader industry context. It reflects individual director activity rather than company-wide strategic or operational trends.

Comparison to Industry Standards

  • NA

Stakeholder Impact

  • Shareholders: May interpret the sale as a signal, though the exercise and net gain are positive. The overall change in direct ownership is a net increase.
  • Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.

Key Dates

DateDescription
12/14/2020Date stock option was awarded.
12/14/2021Date option became exercisable.
01/16/2026Date of stock option exercise and acquisition of common stock.
01/20/2026Date of common stock sale.
01/21/2026Date Form 4 was signed.
12/14/2030Option expiration date.

Keywords

ARGAN INC, AGX, Insider Trading, Form 4, Stock Option Exercise, Stock Sale, Director Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.